Article info

Download PDFPDF
Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)

Authors

  1. Address correspondence and reprint requests to Gordon John Sampson Rustin, MD, MSc, FRCP, Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, Middlesex HA62RN, UK. E-mail: grustin{at}nhs.net.

Citation

Rustin GJS, Vergote I, Eisenhauer E, et al
Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)

Publication history

  • Received August 2, 2010
  • First published January 1, 2011.
Online issue publication 
January 01, 2011

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.